​

Funding Round

Series C - Generate Biomedicines

Series C - Generate Biomedicines

Investment Firm

Overview

Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.

Announced Date

Sep 15, 2023

Closed on Date

Sep 14, 2023

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

11

Investor Name
Participant InvestorT. Rowe Price
Participant InvestorARCH Venture Partners
Participant InvestorMarch Capital
Participant InvestorFidelity
Participant InvestorFlagship Pioneering

Round Details and Background

Generate Biomedicines raised $273000000 on 2023-09-15 in Series C

Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 10, 2020
Series A - Generate Biomedicines
2-50.0M
Nov 18, 2021
Series B - Generate Biomedicines
8-370.0M
Sep 15, 2023
Series C - Generate Biomedicines
12-273.0M

Recent Activity

There is no recent news or activity for this profile.